Plant ribonucleases and nucleases as antiproliferative agens targeting human tumors growing in mice

Jaroslav Matousek1, Josef Matousek

  • 1Biology Centre, Academy of Sciences of the Czech Republic v.v.i., Institute of Plant Molecular Biology, Ceské Budejovice. matousek@iapg.cas.cz

Insights

Plant nucleases show negligible antiproliferative effects in vitro but significant antitumor activity in vivo against melanoma. Recombinant nucleases, like TBN1 and HBN1, demonstrate potent cytostatic effects in vivo, offering a promising cancer therapy approach.

Area of Science:

  • Biochemistry
  • Oncology
  • Enzymology

Background:

  • Plant-derived ribonucleases (RNases) are being investigated for potential therapeutic applications.
  • Previous studies have shown varying efficacy of different nucleases against cancer cell lines and tumors.

Purpose of the Study:

  • To evaluate the in vitro and in vivo antitumor and antiproliferative effects of various plant nucleases.
  • To assess the efficacy of recombinant tomato (TBN1) and hop (HBN1) nucleases against human melanoma tumors.

Main Methods:

  • In vitro testing on human ML-2 tumor cell line.
  • In vivo studies on athymic nude mice bearing human melanoma tumors.
  • Administration of nucleases as stabilized conjugates with polyethylene glycol (PEG).

Main Results:

  • Plant nucleases exhibited negligible in vitro antiproliferative activity but significant in vivo antitumor effects on melanoma.
  • Recombinant TBN1 and HBN1 nucleases showed strong in vivo cytostatic effects.
  • Recombinant nucleases were effective at concentrations ten times lower than bovine seminal RNase (BS-RNase).

Conclusions:

  • Plant nucleases, particularly recombinant TBN1 and HBN1, possess significant in vivo antitumor potential against melanoma.
  • PEG-stabilized recombinant nucleases offer a promising strategy for cancer therapy due to their potent in vivo activity and reduced dosage requirements.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...